Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$27.7 - $35.48 $6,841 - $8,763
-247 Reduced 9.25%
2,422 $70,000
Q3 2023

Nov 14, 2023

BUY
$30.68 - $40.09 $5,522 - $7,216
180 Added 7.23%
2,669 $81,000
Q2 2023

Aug 10, 2023

BUY
$36.12 - $47.5 $3,034 - $3,990
84 Added 3.49%
2,489 $99,000
Q1 2023

May 15, 2023

SELL
$35.53 - $43.38 $13,252 - $16,180
-373 Reduced 13.43%
2,405 $98,000
Q4 2022

Jun 14, 2023

BUY
$38.19 - $57.45 $14,244 - $21,428
373 Added 15.51%
2,778 $107 Million
Q4 2022

Mar 30, 2023

BUY
$38.19 - $57.45 $3,704 - $5,572
97 Added 3.62%
2,778 $107,000
Q4 2022

Feb 15, 2023

BUY
$38.19 - $57.45 $3,704 - $5,572
97 Added 3.62%
2,778 $107,000
Q3 2022

Jun 14, 2023

BUY
$51.24 - $58.89 $14,142 - $16,253
276 Added 11.48%
2,681 $143 Million
Q2 2022

Jun 20, 2023

BUY
$51.49 - $81.64 $14,211 - $22,532
276 Added 11.48%
2,681 $156,000
Q1 2022

Jun 20, 2023

BUY
$60.03 - $76.49 $16,568 - $21,111
276 Added 11.48%
2,681 $204,000
Q1 2022

Mar 30, 2023

SELL
$60.03 - $76.49 $553,776 - $705,620
-9,225 Reduced 77.48%
2,681 $204,000
Q1 2022

May 12, 2022

SELL
$60.03 - $76.49 $553,776 - $705,620
-9,225 Reduced 77.48%
2,681 $205,000
Q4 2021

Jun 21, 2023

BUY
$47.97 - $62.21 $455,762 - $591,057
9,501 Added 395.05%
11,906 $716,000
Q3 2021

Jun 21, 2023

BUY
$54.64 - $61.3 $519,134 - $582,411
9,501 Added 395.05%
11,906 $666,000
Q2 2021

Jun 21, 2023

BUY
$59.18 - $69.99 $562,269 - $664,974
9,501 Added 395.05%
11,906 $722,000
Q2 2021

Mar 30, 2023

BUY
$59.18 - $69.99 $46,693 - $55,222
789 Added 7.1%
11,906 $722,000
Q2 2021

Aug 16, 2021

BUY
$59.18 - $69.99 $703,946 - $832,531
11,895 Added 108136.36%
11,906 $722,000
Q1 2021

Jun 26, 2023

BUY
$59.31 - $78.82 $516,708 - $686,679
8,712 Added 362.25%
11,117 $779 Million
Q1 2021

Mar 30, 2023

SELL
$59.31 - $78.82 $92,582 - $123,038
-1,561 Reduced 12.31%
11,117 $779,000
Q1 2021

May 14, 2021

SELL
$59.31 - $78.82 $751,279 - $998,412
-12,667 Reduced 99.91%
11 $779,000
Q4 2020

Jun 22, 2023

BUY
$50.47 - $66.26 $518,478 - $680,688
10,273 Added 427.15%
12,678 $758,000
Q3 2020

Jun 26, 2023

BUY
$51.97 - $63.0 $533,887 - $647,199
10,273 Added 427.15%
12,678 $762,000
Q2 2020

Jun 26, 2023

BUY
$30.8 - $52.47 $316,408 - $539,024
10,273 Added 427.15%
12,678 $665,000
Q2 2020

Mar 30, 2023

SELL
$30.8 - $52.47 $8,131 - $13,852
-264 Reduced 2.04%
12,678 $665,000
Q2 2020

Aug 14, 2020

SELL
$30.8 - $52.47 $8,131 - $13,852
-264 Reduced 2.04%
12,678 $665,000
Q1 2020

Jul 12, 2023

BUY
$28.4 - $50.7 $299,250 - $534,225
10,537 Added 438.13%
12,942 $433,000
Q4 2019

Jul 12, 2023

BUY
$36.31 - $46.83 $382,598 - $493,447
10,537 Added 438.13%
12,942 $586,000
Q4 2019

Mar 30, 2023

SELL
$36.31 - $46.83 $14,705 - $18,966
-405 Reduced 3.03%
12,942 $586,000
Q4 2019

Feb 14, 2020

SELL
$36.31 - $46.83 $14,705 - $18,966
-405 Reduced 3.03%
12,942 $586,000
Q3 2019

Jul 12, 2023

BUY
$35.66 - $44.99 $390,191 - $492,280
10,942 Added 454.97%
13,347 $508,000
Q2 2019

Jul 12, 2023

BUY
$36.57 - $47.97 $400,148 - $524,887
10,942 Added 454.97%
13,347 $580,000
Q1 2019

Jul 13, 2023

BUY
$36.47 - $42.17 $399,054 - $461,424
10,942 Added 454.97%
13,347 $507,000
Q1 2019

Mar 30, 2023

BUY
$36.47 - $42.17 $385,451 - $445,694
10,569 Added 380.45%
13,347 $507,000
Q1 2019

May 16, 2019

SELL
$36.47 - $42.17 $113,786 - $131,570
-3,120 Reduced 18.95%
13,347 $507,000
Q1 2019

May 15, 2019

BUY
$36.47 - $42.17 $113,786 - $131,570
3,120 Added 23.38%
16,467 $74,000
Q4 2018

Jul 13, 2023

BUY
$41.31 - $52.16 $452,014 - $570,734
10,942 Added 454.97%
13,347 $574,000
Q4 2018

Feb 14, 2019

BUY
$41.31 - $52.16 $438,588 - $553,782
10,617 Added 388.9%
13,347 $574,000
Q3 2018

Jul 13, 2023

BUY
$32.85 - $52.0 $347,125 - $549,484
10,567 Added 439.38%
12,972 $638 Million
Q3 2018

Nov 14, 2018

SELL
$32.85 - $52.0 $336,449 - $532,584
-10,242 Reduced 78.95%
2,730 $134,000
Q4 2017

Feb 15, 2018

SELL
$31.85 - $46.95 $436,631 - $643,637
-13,709 Reduced 51.38%
12,972 $592,000
Q2 2017

Aug 14, 2017

BUY
N/A
26,681
26,681 $1.27 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.